Billiontoone (NASDAQ:BLLN) SVP Sells 2,834 Shares of Company Stock

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) SVP Bosch John Roderick Ten sold 2,834 shares of Billiontoone stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $105.15, for a total value of $297,995.10. Following the transaction, the senior vice president directly owned 19,385 shares of the company’s stock, valued at $2,038,332.75. The trade was a 12.75% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

  • On Thursday, September 24th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total transaction of $169,920.00.
  • On Monday, September 21st, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $106.61, for a total transaction of $150,959.76.
  • On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $97.54, for a total transaction of $138,116.64.
  • On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total transaction of $141,700.00.
  • On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total transaction of $131,582.62.

Billiontoone Price Performance

Shares of BLLN traded down $4.19 during mid-day trading on Wednesday, reaching $95.75. 679,799 shares of the stock traded hands, compared to its average volume of 656,006. The company has a market cap of $4.52 billion and a price-to-earnings ratio of 136.79. Billiontoone, Inc. has a 1 year low of $61.96 and a 1 year high of $150.44. The firm has a fifty day moving average price of $105.26 and a 200 day moving average price of $100.66. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17.

Billiontoone (NASDAQ:BLLN – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.15. The company had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. As a group, equities research analysts predict that Billiontoone, Inc. will post 0.83 earnings per share for the current year.

Analysts Set New Price Targets

BLLN has been the subject of several recent analyst reports. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. JPMorgan Chase & Co. lowered their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research note on Thursday, August 6th. Guggenheim lifted their target price on shares of Billiontoone from $125.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Zacks Research raised shares of Billiontoone from a “strong sell” rating to a “hold” rating in a research note on Friday, October 2nd. Finally, BTIG Research lowered their price objective on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Seven investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Billiontoone presently has an average rating of “Moderate Buy” and an average target price of $126.25.

Check Out Our Latest Research Report on BLLN

Hedge Funds Weigh In On Billiontoone

Hedge funds and other institutional investors have recently modified their holdings of the company. Integrated Wealth Concepts LLC purchased a new position in shares of Billiontoone during the 2nd quarter valued at about $29,000. MCF Advisors LLC boosted its stake in Billiontoone by 330.8% in the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock worth $54,000 after buying an additional 344 shares in the last quarter. Family Legacy Financial Solutions LLC bought a new position in Billiontoone during the third quarter valued at approximately $53,000. Thrive Wealth Management LLC bought a new position in Billiontoone during the second quarter valued at approximately $240,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Billiontoone during the fourth quarter worth approximately $230,000.

Billiontoone Company Profile

(Get Free Report)

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.

Read More

Insider Buying and Selling by Quarter for Billiontoone (NASDAQ:BLLN)

Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.